Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, M A Khamashta, Y Shoenfeld, M T Camps, S Jacobsen, E Kiss, M M Zeher, A Tincani, I Kontopoulou-Griva, M Galeazzi, F Bellisai, P L Meroni, R H W M Derksen, P G de Groot, E Gromnica-Ihle, M Baleva, M Mosca, S Bombardieri, F Houssiau, J-C GrisI Quéré, E Hachulla, C Vasconcelos, B Roch, A Fernández-Nebro, J-C Piette, G Espinosa, S Bucciarelli, C N Pisoni, M L Bertolaccini, M-C Boffa, G R V Hughes, Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)

    260 Citationer (Scopus)

    Abstract

    To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with prognostic significance.
    OriginalsprogEngelsk
    TidsskriftAnnals of the Rheumatic Diseases
    Vol/bind68
    Udgave nummer9
    Sider (fra-til)1428-32
    Antal sider5
    ISSN0003-4967
    DOI
    StatusUdgivet - 1 sep. 2009

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients'. Sammen danner de et unikt fingeraftryk.

    Citationsformater